The effect of omega-3 fatty acid supplementation on serum lipids and other cardiovascular risk markers, with results stratified by PPARG genotype, were recently determined in a randomized and double-blinded placebo-controlled clinical trial published in Nutrients. One hundred and two adults between the ages of 40 to 75 with an LDL-C between 70 and 190 mg/dL…